Cargando…

The Anti-Inflammatory Effect of Feiyangchangweiyan Capsule and Its Main Components on Pelvic Inflammatory Disease in Rats via the Regulation of the NF-κB and BAX/BCL-2 Pathway

Although gastroenteritis and pelvic inflammatory disease (PID) occur in the gastrointestinal tract and pelvis, respectively, they display similar pathogeneses. The incidence of inflammation in these conditions is usually associated with dysbacteriosis, and, at times, they are caused by the same path...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yao, Yang, Qian, Shi, Zhi-hui, Zhou, Min, Yan, Li, Li, Hua, Xie, Yan-hua, Wang, Si-wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595388/
https://www.ncbi.nlm.nih.gov/pubmed/31312226
http://dx.doi.org/10.1155/2019/9585727
_version_ 1783430392111431680
author Li, Yao
Yang, Qian
Shi, Zhi-hui
Zhou, Min
Yan, Li
Li, Hua
Xie, Yan-hua
Wang, Si-wang
author_facet Li, Yao
Yang, Qian
Shi, Zhi-hui
Zhou, Min
Yan, Li
Li, Hua
Xie, Yan-hua
Wang, Si-wang
author_sort Li, Yao
collection PubMed
description Although gastroenteritis and pelvic inflammatory disease (PID) occur in the gastrointestinal tract and pelvis, respectively, they display similar pathogeneses. The incidence of inflammation in these conditions is usually associated with dysbacteriosis, and, at times, they are caused by the same pathogenic bacteria, Escherichia coli and Streptococcus aureus. Feiyangchangweiyan capsule (FYC) is a traditional Chinese patent medicine that is widely used to treat bacterial dysentery and acute and chronic gastroenteritis. However, whether it has an effect on PID is unclear. The aim of this study was to investigate the anti-inflammatory effect of FYC and its main components, gallic acid (GA), ellagic acid (EA), and syringin (SY), on a pathogen-induced PID model and illustrate their potential mechanism of action. Female specific pathogen-free SD rats (n = 1110) were randomly divided into control, PID, FYC, GA, EA, SY, GA + EA, GA + SY, EA + SY, GA + EA + SY, and Fuke Qianjin capsule (FKC) positive groups. Histological examination and enzyme-linked immunosorbent assay (ELISA) were carried out as well as western blot analysis to detect the expression of NF-κB, BAX, BCL-2, and JNK. In this study, FYC and its main components dramatically suppressed the infiltration of inflammatory cells, reduced the production of IL-1β, TNF-α, and MCP-1, and elevated the IL-10 level to varying degrees. We also found that FYC and its main components inhibited the expression of BAX induced by infection and increased the expression of Bcl-2. FYC, GA, EA, and SY could also block the activation of the NF-κB pathway. Finally, we found that the phosphorylation of JNK could be decreased by FYC, GA, and SY. FYC and its main components exhibit anti-inflammatory effect on a pathogen-induced PID model by regulating the NF-κB and apoptosis signaling pathways.
format Online
Article
Text
id pubmed-6595388
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-65953882019-07-16 The Anti-Inflammatory Effect of Feiyangchangweiyan Capsule and Its Main Components on Pelvic Inflammatory Disease in Rats via the Regulation of the NF-κB and BAX/BCL-2 Pathway Li, Yao Yang, Qian Shi, Zhi-hui Zhou, Min Yan, Li Li, Hua Xie, Yan-hua Wang, Si-wang Evid Based Complement Alternat Med Research Article Although gastroenteritis and pelvic inflammatory disease (PID) occur in the gastrointestinal tract and pelvis, respectively, they display similar pathogeneses. The incidence of inflammation in these conditions is usually associated with dysbacteriosis, and, at times, they are caused by the same pathogenic bacteria, Escherichia coli and Streptococcus aureus. Feiyangchangweiyan capsule (FYC) is a traditional Chinese patent medicine that is widely used to treat bacterial dysentery and acute and chronic gastroenteritis. However, whether it has an effect on PID is unclear. The aim of this study was to investigate the anti-inflammatory effect of FYC and its main components, gallic acid (GA), ellagic acid (EA), and syringin (SY), on a pathogen-induced PID model and illustrate their potential mechanism of action. Female specific pathogen-free SD rats (n = 1110) were randomly divided into control, PID, FYC, GA, EA, SY, GA + EA, GA + SY, EA + SY, GA + EA + SY, and Fuke Qianjin capsule (FKC) positive groups. Histological examination and enzyme-linked immunosorbent assay (ELISA) were carried out as well as western blot analysis to detect the expression of NF-κB, BAX, BCL-2, and JNK. In this study, FYC and its main components dramatically suppressed the infiltration of inflammatory cells, reduced the production of IL-1β, TNF-α, and MCP-1, and elevated the IL-10 level to varying degrees. We also found that FYC and its main components inhibited the expression of BAX induced by infection and increased the expression of Bcl-2. FYC, GA, EA, and SY could also block the activation of the NF-κB pathway. Finally, we found that the phosphorylation of JNK could be decreased by FYC, GA, and SY. FYC and its main components exhibit anti-inflammatory effect on a pathogen-induced PID model by regulating the NF-κB and apoptosis signaling pathways. Hindawi 2019-06-13 /pmc/articles/PMC6595388/ /pubmed/31312226 http://dx.doi.org/10.1155/2019/9585727 Text en Copyright © 2019 Yao Li et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Yao
Yang, Qian
Shi, Zhi-hui
Zhou, Min
Yan, Li
Li, Hua
Xie, Yan-hua
Wang, Si-wang
The Anti-Inflammatory Effect of Feiyangchangweiyan Capsule and Its Main Components on Pelvic Inflammatory Disease in Rats via the Regulation of the NF-κB and BAX/BCL-2 Pathway
title The Anti-Inflammatory Effect of Feiyangchangweiyan Capsule and Its Main Components on Pelvic Inflammatory Disease in Rats via the Regulation of the NF-κB and BAX/BCL-2 Pathway
title_full The Anti-Inflammatory Effect of Feiyangchangweiyan Capsule and Its Main Components on Pelvic Inflammatory Disease in Rats via the Regulation of the NF-κB and BAX/BCL-2 Pathway
title_fullStr The Anti-Inflammatory Effect of Feiyangchangweiyan Capsule and Its Main Components on Pelvic Inflammatory Disease in Rats via the Regulation of the NF-κB and BAX/BCL-2 Pathway
title_full_unstemmed The Anti-Inflammatory Effect of Feiyangchangweiyan Capsule and Its Main Components on Pelvic Inflammatory Disease in Rats via the Regulation of the NF-κB and BAX/BCL-2 Pathway
title_short The Anti-Inflammatory Effect of Feiyangchangweiyan Capsule and Its Main Components on Pelvic Inflammatory Disease in Rats via the Regulation of the NF-κB and BAX/BCL-2 Pathway
title_sort anti-inflammatory effect of feiyangchangweiyan capsule and its main components on pelvic inflammatory disease in rats via the regulation of the nf-κb and bax/bcl-2 pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595388/
https://www.ncbi.nlm.nih.gov/pubmed/31312226
http://dx.doi.org/10.1155/2019/9585727
work_keys_str_mv AT liyao theantiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT yangqian theantiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT shizhihui theantiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT zhoumin theantiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT yanli theantiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT lihua theantiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT xieyanhua theantiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT wangsiwang theantiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT liyao antiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT yangqian antiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT shizhihui antiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT zhoumin antiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT yanli antiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT lihua antiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT xieyanhua antiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway
AT wangsiwang antiinflammatoryeffectoffeiyangchangweiyancapsuleanditsmaincomponentsonpelvicinflammatorydiseaseinratsviatheregulationofthenfkbandbaxbcl2pathway